Your browser doesn't support javascript.
loading
Pertuzumab as second­ or later­line therapy for human epidermal growth factor receptor 2­positive metastatic breast cancer: A clinical experience.
Biskup, Ewelina; Sartorius, Céline Montavon; Müller, Andreas; Leo, Cornelia; Nussbaum, Catrina Uhlmann; Georgescu Margarint, Elena Laura; Koychev, Daniel; Schreiber, Alexander; Taverna, Christian; Thorn, David; Vetter, Marcus.
Afiliación
  • Biskup E; Department of Basic and Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China.
  • Sartorius CM; Department of Advanced Biomedical Sciences, Federico II University of Naples, I-80131 Naples, Italy.
  • Müller A; Department of Medical Oncology and Breast Cancer Center, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
  • Leo C; Department of Medical Oncology and Breast Cancer Center, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
  • Nussbaum CU; Canton Hospital Winterthur (Med. Oncology), 8400 Winterthur, Switzerland.
  • Georgescu Margarint EL; Department of Gynecology, Canton Hospital Baden, 5404 Baden, Switzerland.
  • Koychev D; Department of Internal Medicine, Canton Hospital Olten, 4600 Olten, Switzerland.
  • Schreiber A; Shanghai East International Medical Center, Shanghai 200120, P.R. China.
  • Taverna C; Tumor Center ZeTuP, 8640 Rapperswil, Switzerland.
  • Thorn D; Canton Hospital Aarau, 5001 Aarau, Switzerland.
  • Vetter M; Canton Hospital Muensterlingen, 8596 Münsterlingen, Switzerland.
Mol Clin Oncol ; 19(1): 52, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37303973

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Clin Oncol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Clin Oncol Año: 2023 Tipo del documento: Article